A detailed history of Horizon Kinetics Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 114,762 shares of CRL stock, worth $22.5 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
114,762
Previous 160,381 28.44%
Holding current value
$22.5 Million
Previous $33.1 Million 31.77%
% of portfolio
0.37%
Previous 0.62%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $8.57 Million - $11.2 Million
-45,619 Reduced 28.44%
114,762 $22.6 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $241,476 - $314,414
1,170 Added 0.73%
160,381 $33.1 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $4.77 Million - $6.41 Million
-23,453 Reduced 12.84%
159,211 $43.1 Million
Q4 2023

Feb 15, 2024

SELL
$164.52 - $238.84 $5.19 Million - $7.54 Million
-31,571 Reduced 14.74%
182,664 $43.2 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $3.55 Million - $3.97 Million
-18,265 Reduced 7.86%
214,235 $42 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $2.66 Million - $3.04 Million
-14,468 Reduced 5.86%
232,500 $48.9 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $2.52 Million - $3.41 Million
-13,125 Reduced 5.05%
246,968 $49.8 Million
Q4 2022

Feb 07, 2023

SELL
$197.11 - $250.07 $4.79 Million - $6.08 Million
-24,296 Reduced 8.54%
260,093 $56.7 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $2.66 Million - $3.65 Million
-14,585 Reduced 4.88%
284,389 $56 Million
Q2 2022

Aug 05, 2022

BUY
$204.13 - $302.4 $4.85 Million - $7.18 Million
23,735 Added 8.62%
298,974 $64 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $12.2 Million - $17.4 Million
47,933 Added 21.09%
275,239 $78.2 Million
Q4 2021

Feb 15, 2022

BUY
$351.38 - $448.68 $6.86 Million - $8.76 Million
19,514 Added 9.39%
227,306 $85.6 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $4.11 Million - $5.06 Million
11,038 Added 5.61%
207,792 $85.7 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $22.3 Million - $28.2 Million
75,962 Added 62.89%
196,754 $72.8 Million
Q1 2021

May 11, 2021

BUY
$249.67 - $299.48 $2.27 Million - $2.72 Million
9,074 Added 8.12%
120,792 $35 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $641,358 - $729,819
-2,889 Reduced 2.52%
111,718 $27.9 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $114,816 - $148,098
654 Added 0.57%
114,607 $26 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $8.94 Million - $14.3 Million
75,262 Added 194.52%
113,953 $19.9 Million
Q1 2020

May 13, 2020

BUY
$98.9 - $178.34 $3.83 Million - $6.9 Million
38,691 New
38,691 $4.88 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.